We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrulis Slaps Celgene with Method-Of-Use Patent Suit
Andrulis Slaps Celgene with Method-Of-Use Patent Suit
October 11, 2013
Andrulis Pharmaceuticals has slapped Celgene with a lawsuit claiming its competitor illegally encourages physicians to prescribe a combination of cancer drugs covered by its method patent.